Sutfin T A, Lind T, Gabrielsson M, Regårdh C G
Department of Pharmacokinetics and Drug Metabolism, AB Hässle, Mölndal, Sweden.
Eur J Clin Pharmacol. 1990;38(5):421-4. doi: 10.1007/BF02336677.
The biliary secretion of [14C]felodipine in 4 healthy human subjects was studied by use of the multiple marker dilution principle with double lumen tubes placed in the stomach and intestine. Insignificant amounts of 14C activity were recovered from gastric aspirates. The individual recovery from intestinal aspirates varied from 2.9 to 8.5% of the dose of radioactivity over the period of 4.5 h after dosing. Less than 0.1% was identified as unchanged felodipine. The results show that biliary secretion is a minor route of elimination of felodipine or its metabolites. Bile collection for 4.5 h had no significant effect on the pharmacokinetics of felodipine, although the 72 h urinary recovery of radioactivity tended to be lower when bile was collected (59%) than in the control experiment (66%).
通过使用多标记稀释原理,将双腔管置于胃和肠道中,对4名健康受试者的[14C]非洛地平胆汁分泌情况进行了研究。从胃吸出物中回收的14C活性量微不足道。给药后4.5小时内,从肠道吸出物中的个体回收率在给药剂量的放射性的2.9%至8.5%之间。鉴定出不到0.1%为未变化的非洛地平。结果表明,胆汁分泌是非洛地平或其代谢物的次要消除途径。收集4.5小时胆汁对非洛地平的药代动力学没有显著影响,尽管收集胆汁时放射性的72小时尿液回收率(59%)往往低于对照实验(66%)。